Finance

Lists
Outlook: 34.6% bullish·3.9% bearish
Go to analysis
ACN:NYSE
Accenture Plc
$260.94
+1.05%
(+2.70) 1D
$260.94
0.00% (0.00)
After hours
Closed: Nov 2, 4:00:06 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACN...
Open
$255.70
High
$263.66
Low
$253.68
Mkt. cap
154.15B
Avg. vol.
7.44M
Volume
5.79M
Dividend
2.62%
Quarterly dividend
$1.71
Ex-dividend date
Oct 13, 2026
P/E ratio
19.24
52-wk high
$291.09
52-wk low
$118.15
EPS
$13.56
Beta
1.11
Shares outstanding
590.74M
No. of employees
814K
Open
$255.70
High
$263.66
Low
$253.68
Mkt. cap
154.15B
Avg. vol.
7.44M
Volume
5.79M
Dividend
2.62%
Quarterly dividend
$1.71
Ex-dividend date
Oct 13, 2026
P/E ratio
19.24
52-wk high
$291.09
52-wk low
$118.15
EPS
$13.56
Beta
1.11
Shares outstanding
590.74M
No. of employees
814K
News stories
From web sources and news partners
Profile
Accenture plc is a technology consulting company headquartered in Dublin, Ireland. Founded in 1989 in the United States, Accenture provides information technology and management consulting services across 120 countries globally. Wikipedia
About Accenture Plc
CEOJean-Marc Ollagnier | Julie Sweet
Employees814K
Founded1989
Headquarters-
SectorInformation technology consulting
Websiteaccenture.com
Analyst ratings
Based on 23 analysts giving stock ratings to ACN in the past 3 months
Buy
Buy
10
Hold
13
Sell
0
12-month forecast
Based on 23 Wall Street analysts offering 12 month price targets for ACN in the last 3 months.
Highest
Current $260.94
$300.00 (+14.97%)
Average
$230.45 (-11.68%)
Lowest
$175.00 (-32.93%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kevin Mcveigh
UBS
Buy
Maintained
$300.00
+15%
10/26/2026
Jason Kupferberg
Wells Fargo
Hold
Reiterated
$252.00
-3.4%
10/26/2026
David Koning
Robert W. Baird
Hold
Downgraded
$252.00
-3.4%
10/21/2026
David Grossman
Stifel Nicolaus
Buy
Maintained
$242.00
-7.3%
10/15/2026
Amit Daryanani
Evercore ISI
Buy
Maintained
$250.00
-4.2%
10/15/2026
James Schneider
Goldman Sachs
Buy
Maintained
$260.00
-0.4%
10/14/2026
Bryan Bergin
TD Cowen
Hold
Reiterated
$201.00
-23%
10/15/2026
David Paige
RBC Capital
Buy
Maintained
$240.00
-8%
10/14/2026
Keith Bachman
BMO Capital
Hold
Maintained
$235.00
-9.9%
10/14/2026
James Faucette
Morgan Stanley
Hold
Maintained
$195.00
-25.3%
10/15/2026
James Friedman
Susquehanna
Hold
Maintained
$230.00
-11.9%
10/15/2026
Sachin Mittal
DBS
Hold
Maintained
$216.00
-17.2%
10/12/2026
Unknown Analyst
Berenberg Bank
Buy
Maintained
$235.00
-9.9%
10/05/2026
Sean Kennedy
Mizuho Securities
Buy
Maintained
$241.00
-7.6%
10/05/2026
Dan Dolev
Mizuho Securities
Buy
Maintained
$241.00
-7.6%
10/05/2026
Arvind Ramnani
Truist Financial
Hold
Maintained
-
-
10/02/2026
Jim Kelleher
Argus Research
Buy
Reiterated
$260.00
-0.4%
10/01/2026
Daniel Perlin
RBC Capital
Buy
Maintained
$240.00
-8%
10/01/2026
Bryan Keane
Citi
Hold
Maintained
$220.00
-15.7%
10/02/2026
Surinder Thind
Jefferies
Hold
Maintained
$190.00
-27.2%
10/01/2026
Maggie Nolan
William Blair
Hold
Maintained
-
-
10/01/2026
Tien Tsin Huang
J.P. Morgan
Buy
Reiterated
$200.00
-23.4%
09/25/2026
Terry Tillman
Truist Financial
Hold
Maintained
-
-
09/21/2026
Nate Svensson
Deutsche Bank
Hold
Maintained
$175.00
-32.9%
09/18/2026
Jonathan Lee CFA
Guggenheim
Hold
Downgraded
-
-
09/20/2026
Darrin Peller
Wolfe Research
Buy
Maintained
$215.00
-17.6%
08/25/2026
Meha Pau
Berenberg Bank
Buy
Maintained
$220.00
-15.7%
06/16/2026
Phani Kanumuri
HSBC
Hold
Upgraded
$220.00
-15.7%
03/20/2026
Arun Viswanathan
RBC Capital
Buy
Reiterated
$253.00
-3%
03/19/2026
Last report
Oct 1, 2026
Fiscal period
Q4 2026
$3.29 / $3.18
+3.36%beat
Revenue / Est. (USD)
18.68B / 18.04B
+3.56%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Nov 2025
Feb 2026
May 2026
Aug 2026
Revenue
18.74B
18.04B
18.72B
18.68B
Cost of goods sold
12.55B
12.58B
12.58B
12.69B
Cost of revenue
12.55B
12.58B
12.58B
12.69B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.02B
2.97B
2.96B
2.65B
Operating expense
3.02B
2.97B
2.96B
2.65B
Total operating expenses
15.56B
15.55B
15.54B
15.35B
Operating income
3.18B
2.49B
3.18B
3.33B
Other non operating income
77.84M
-39.14M
28.30M
-474.38M
EBT including unusual items
2.97B
2.46B
3.15B
2.80B
EBT excluding unusual items
3.28B
2.46B
3.15B
2.80B
Income tax expense
725.77M
597.27M
761.94M
764.36M
Effective tax rate
24.46%
24.31%
24.19%
27.32%
Other operating expenses
-
-
-
-
Net income
2.21B
1.83B
2.34B
1.99B
Net profit margin
11.80%
10.12%
12.50%
10.66%
Earnings per share
3.94
2.93
3.80
3.29
Interest and investment income
106.22M
78.54M
75.07M
103.38M
Interest expense
-65.36M
-63.57M
-70.64M
-103.82M
Net interest expenses
40.86M
14.97M
4.42M
-444.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
3.48B
2.81B
3.48B
3.65B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps